HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions
- Autores
- Domínguez, Wendy Gabriela; Nardi, Héctor; Montero, Héctor; Vincent, Esteban; Corte, María Marta; Balogh, Gabriela Andrea
- Año de publicación
- 2010
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The objective of this pilot project was to investigate whether the breast fine needle aspiration (FNA) technique is a useful tool for determining the increased risk of breast cancer in patients with non-palpable breast lesions. FNA is a minimally invasive technique that isolates mammary epithelial cells from breast cells in the suspicious region. In this study, two FNA samples were collected from 12 patients. The level of HER2/neu expression at the mRNA level (in serum) was measured in each patient. As gene amplification is characteristic of cancer cells and may assist in diagnosis and prognostic assessment, it is crucial that gene amplification of HER2/neu in patients with non-palpable breast lesions is compared to breast biopsy results. In serum, the level of HER2/neu was determined by ELISA assay. Gene amplification was determined by PCR and confirmed by IHC employing monoclonal ERRB2 in the FNA sample. The results indicate that FNA has a good correlation with breast biopsy. FNA combined with mammographic imaging is a strong tool for determining favorable treatment options for patients.
Fil: Domínguez, Wendy Gabriela. Texas A&M University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Centro de Recursos Naturales Renovables de la Zona Semiarida. Universidad Nacional del Sur. Centro de Recursos Naturales Renovables de la Zona Semiarida; Argentina
Fil: Nardi, Héctor. Hospital Interzonal Dr José Penna. Departamento de Ginecología. Bahía Blanca; Argentina
Fil: Montero, Héctor. Hospital Español. Departamento de Ginecología; Argentina
Fil: Vincent, Esteban. Hospital de la Asociación Médica de Bahía Blanca. Departamento de Ginecología. Bahía Blanca; Argentina
Fil: Corte, María Marta. Laboratorio de Patología. Bahía Blanca; Argentina
Fil: Balogh, Gabriela Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Centro de Recursos Naturales Renovables de la Zona Semiarida. Universidad Nacional del Sur. Centro de Recursos Naturales Renovables de la Zona Semiarida; Argentina - Materia
-
BREAST FINE NEEDLE ASPIRATION
GENE EXPRESSION
HER2/NEU
NON-PALPABLE BREAST CARCINOMA - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/15967
Ver los metadatos del registro completo
id |
CONICETDig_434eaefcba8fb17da36d652602e42f27 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/15967 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesionsDomínguez, Wendy GabrielaNardi, HéctorMontero, HéctorVincent, EstebanCorte, María MartaBalogh, Gabriela AndreaBREAST FINE NEEDLE ASPIRATIONGENE EXPRESSIONHER2/NEUNON-PALPABLE BREAST CARCINOMAhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3The objective of this pilot project was to investigate whether the breast fine needle aspiration (FNA) technique is a useful tool for determining the increased risk of breast cancer in patients with non-palpable breast lesions. FNA is a minimally invasive technique that isolates mammary epithelial cells from breast cells in the suspicious region. In this study, two FNA samples were collected from 12 patients. The level of HER2/neu expression at the mRNA level (in serum) was measured in each patient. As gene amplification is characteristic of cancer cells and may assist in diagnosis and prognostic assessment, it is crucial that gene amplification of HER2/neu in patients with non-palpable breast lesions is compared to breast biopsy results. In serum, the level of HER2/neu was determined by ELISA assay. Gene amplification was determined by PCR and confirmed by IHC employing monoclonal ERRB2 in the FNA sample. The results indicate that FNA has a good correlation with breast biopsy. FNA combined with mammographic imaging is a strong tool for determining favorable treatment options for patients.Fil: Domínguez, Wendy Gabriela. Texas A&M University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Centro de Recursos Naturales Renovables de la Zona Semiarida. Universidad Nacional del Sur. Centro de Recursos Naturales Renovables de la Zona Semiarida; ArgentinaFil: Nardi, Héctor. Hospital Interzonal Dr José Penna. Departamento de Ginecología. Bahía Blanca; ArgentinaFil: Montero, Héctor. Hospital Español. Departamento de Ginecología; ArgentinaFil: Vincent, Esteban. Hospital de la Asociación Médica de Bahía Blanca. Departamento de Ginecología. Bahía Blanca; ArgentinaFil: Corte, María Marta. Laboratorio de Patología. Bahía Blanca; ArgentinaFil: Balogh, Gabriela Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Centro de Recursos Naturales Renovables de la Zona Semiarida. Universidad Nacional del Sur. Centro de Recursos Naturales Renovables de la Zona Semiarida; ArgentinaSpandidos Publ Ltd2010-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/mswordapplication/pdfhttp://hdl.handle.net/11336/15967Domínguez, Wendy Gabriela; Nardi, Héctor; Montero, Héctor; Vincent, Esteban; Corte, María Marta; et al.; HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions; Spandidos Publ Ltd; Experimental and Therapeutic Medicine; 1; 4; 1-7-2010; 597-6021792-09811792-1015enginfo:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445870/info:eu-repo/semantics/altIdentifier/doi/10.3892/etm_00000094info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:11:40Zoai:ri.conicet.gov.ar:11336/15967instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:11:40.879CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions |
title |
HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions |
spellingShingle |
HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions Domínguez, Wendy Gabriela BREAST FINE NEEDLE ASPIRATION GENE EXPRESSION HER2/NEU NON-PALPABLE BREAST CARCINOMA |
title_short |
HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions |
title_full |
HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions |
title_fullStr |
HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions |
title_full_unstemmed |
HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions |
title_sort |
HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions |
dc.creator.none.fl_str_mv |
Domínguez, Wendy Gabriela Nardi, Héctor Montero, Héctor Vincent, Esteban Corte, María Marta Balogh, Gabriela Andrea |
author |
Domínguez, Wendy Gabriela |
author_facet |
Domínguez, Wendy Gabriela Nardi, Héctor Montero, Héctor Vincent, Esteban Corte, María Marta Balogh, Gabriela Andrea |
author_role |
author |
author2 |
Nardi, Héctor Montero, Héctor Vincent, Esteban Corte, María Marta Balogh, Gabriela Andrea |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
BREAST FINE NEEDLE ASPIRATION GENE EXPRESSION HER2/NEU NON-PALPABLE BREAST CARCINOMA |
topic |
BREAST FINE NEEDLE ASPIRATION GENE EXPRESSION HER2/NEU NON-PALPABLE BREAST CARCINOMA |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The objective of this pilot project was to investigate whether the breast fine needle aspiration (FNA) technique is a useful tool for determining the increased risk of breast cancer in patients with non-palpable breast lesions. FNA is a minimally invasive technique that isolates mammary epithelial cells from breast cells in the suspicious region. In this study, two FNA samples were collected from 12 patients. The level of HER2/neu expression at the mRNA level (in serum) was measured in each patient. As gene amplification is characteristic of cancer cells and may assist in diagnosis and prognostic assessment, it is crucial that gene amplification of HER2/neu in patients with non-palpable breast lesions is compared to breast biopsy results. In serum, the level of HER2/neu was determined by ELISA assay. Gene amplification was determined by PCR and confirmed by IHC employing monoclonal ERRB2 in the FNA sample. The results indicate that FNA has a good correlation with breast biopsy. FNA combined with mammographic imaging is a strong tool for determining favorable treatment options for patients. Fil: Domínguez, Wendy Gabriela. Texas A&M University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Centro de Recursos Naturales Renovables de la Zona Semiarida. Universidad Nacional del Sur. Centro de Recursos Naturales Renovables de la Zona Semiarida; Argentina Fil: Nardi, Héctor. Hospital Interzonal Dr José Penna. Departamento de Ginecología. Bahía Blanca; Argentina Fil: Montero, Héctor. Hospital Español. Departamento de Ginecología; Argentina Fil: Vincent, Esteban. Hospital de la Asociación Médica de Bahía Blanca. Departamento de Ginecología. Bahía Blanca; Argentina Fil: Corte, María Marta. Laboratorio de Patología. Bahía Blanca; Argentina Fil: Balogh, Gabriela Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Centro de Recursos Naturales Renovables de la Zona Semiarida. Universidad Nacional del Sur. Centro de Recursos Naturales Renovables de la Zona Semiarida; Argentina |
description |
The objective of this pilot project was to investigate whether the breast fine needle aspiration (FNA) technique is a useful tool for determining the increased risk of breast cancer in patients with non-palpable breast lesions. FNA is a minimally invasive technique that isolates mammary epithelial cells from breast cells in the suspicious region. In this study, two FNA samples were collected from 12 patients. The level of HER2/neu expression at the mRNA level (in serum) was measured in each patient. As gene amplification is characteristic of cancer cells and may assist in diagnosis and prognostic assessment, it is crucial that gene amplification of HER2/neu in patients with non-palpable breast lesions is compared to breast biopsy results. In serum, the level of HER2/neu was determined by ELISA assay. Gene amplification was determined by PCR and confirmed by IHC employing monoclonal ERRB2 in the FNA sample. The results indicate that FNA has a good correlation with breast biopsy. FNA combined with mammographic imaging is a strong tool for determining favorable treatment options for patients. |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010-07-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/15967 Domínguez, Wendy Gabriela; Nardi, Héctor; Montero, Héctor; Vincent, Esteban; Corte, María Marta; et al.; HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions; Spandidos Publ Ltd; Experimental and Therapeutic Medicine; 1; 4; 1-7-2010; 597-602 1792-0981 1792-1015 |
url |
http://hdl.handle.net/11336/15967 |
identifier_str_mv |
Domínguez, Wendy Gabriela; Nardi, Héctor; Montero, Héctor; Vincent, Esteban; Corte, María Marta; et al.; HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions; Spandidos Publ Ltd; Experimental and Therapeutic Medicine; 1; 4; 1-7-2010; 597-602 1792-0981 1792-1015 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445870/ info:eu-repo/semantics/altIdentifier/doi/10.3892/etm_00000094 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/msword application/pdf |
dc.publisher.none.fl_str_mv |
Spandidos Publ Ltd |
publisher.none.fl_str_mv |
Spandidos Publ Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842270167630872576 |
score |
13.13397 |